Obstetric Genetics Flashcards
Why do patients come to an obstetric genetics clinic?
Have a family history and want info about risks to pregnancy;
Have abnormalities detected on scan- is this a genetic condition?;
Have abnormalities detected on a prenatal test - amniocentesis or CVS
Autosomal dominant
Heterozygous with one copy of the abnormal gene affected
Autosomal recessive
Homozygous with 2 copies of the abnormal gene are affected;
Equally transmitted by males and females;
Inherit 2 Germline mutations, one from each parent to develop the disease;
X-linked recessive
Males with one copy of the abnormal gene on the X chromosome are affected
X-linked recessive inheritance
No male to male transmissions;
Female carriers are unaffected;
All men who inherit mutation are affected;
Appears to skip individuals;
Common X linked recessive disorders
Duchenne muscular dystrophy;
Becker muscular dystrophy;
Haemophilia;
Red-green colour blindness;
Duchenne muscular dystrophy
Most common and severe form of MD;
3-5 years;
Mild-moderate learning difficulties;
Waddling gait, positive Gower sign - difficulty rising from the floor, achieved by ‘climbing up the legs’;
Difficulty running and climbing stairs;
Gradual deterioration - loss of mobility, wheelchair bound;
Progressive muscle weakness;
Common autosomal recessive disorders
Cystic fibrosis;
Hereditary haemochromatosis;
Cystic fibrosis
1 in 2000;
Carrier freq: 1 in 25;
Autosomal recessive;
Progressive lung disease, pancreatic dysfunction, elevated sweat electrolytes;
Affects - respiratory tract, exocrine pancreas, intestine, male genital tract - complex multisystem disease
Prenatal testing
Any test done in the anenatal period for the diagnosis of fetal disease;
Types of prenatal tests
Morphological/Structural - ultrasound; Biochemical - maternal or fetal; Cytogenetic - karyotype; Molecular genetic - cystic fibrosis; Microbiological; Histological; Routine screening - structural anomalies — trisomy 21;
Nuchal Translucency (NT) scan
Between 10-14 weeks gestation;
Thickness of NT measured by ultrasound scan in relation to crown-rump length;
Other anomalies may be detected;
Causes of increased NT
Chromosomal - Down syndrome;
Major congenital heart disease;
Skeletal dysplasias;
Diaphragmatic hernia;
As maternal age increases, the risk of Down syndrome…
Increases
Biochemical serum screening
First trimester -
10-14 weeks gestation (with NT scan);
Accurate dating important to interpret results;
Free beta-human gonadotrophin;
Placenta-associated plasma protein A;
Detection rate of 90% but needs CVS/amnio;
Second trimester -
Alpha-fetoprotein;
Free beta HCG;
Oestriol;
Reduced MSAFP levels indicate?
Down syndrome
Elevated MSAFP levels indicate?
Neural tube defects; Anterior abdominal wall defects; Missed or threatened miscarriage; Intra-uterine growth retardation; Multiple pregnancy; Congenital nephrotic syndrome
Indications for targeted prenatal tests: from personal and family history
Family history of congenital structures abnormalities - neural tube defect;
Diagnostic tests: family history of chromosome abnormality;
Family history of a single gene disorder
Abnormalities identified in pregnancy
Abnormal screening result; Abnormal scan (structural, growth, limb shortening);
Targeted tests - non invasive
Ultrasound scan - surveillance (eg. growth), 3D scan, Fetal echocardiogram;
Fetal MRI scan;
Molecular testing on fetal cells/ DNA in maternal blood for gender or other conditions;
Targeted tests - invasive
CVS;
Amniocentesis;
Cordocentesis;
Fetal tissue biopsy - liver, muscle, skin;
Chorionic villus sampling
11-13 weeks; Transabdominal approach; Chromosomes; Direct prep - 1-2 days; Long term prep - 2 weeks; Good yield of fetal DNA for molecular tests; 1% miscarriage risk;
Amniocentesis
15-16 weeks gestation;
Amniocytes derived from fetal tissues and amnion;
Both amniocytes and supernatant can be used for prenatal tests;
Chromosome analysis takes 2-3 week;
Low yield of fetal DNA;
1% miscarriage risk;
Response to prenatal diagnosis
Current pregnancy:
Continue;
Terminate;
Future pregnancy:
No alteration in reproductive plans;
Prenatal screening/testing;
Restriction of family size/adoption;